GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 44 filers reported holding GENOCEA BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -33.3% | 375,000 | 0.0% | 0.27% | -39.2% |
| Q2 2022 | $6,000 | -98.7% | 375,000 | 0.0% | 0.45% | -98.6% |
| Q1 2022 | $469,000 | +7.8% | 375,000 | 0.0% | 32.06% | +27.4% |
| Q4 2021 | $435,000 | -39.6% | 375,000 | 0.0% | 25.16% | -15.9% |
| Q3 2021 | $720,000 | -18.0% | 375,000 | 0.0% | 29.91% | +917.8% |
| Q2 2021 | $878,000 | -13.6% | 375,000 | 0.0% | 2.94% | +489.0% |
| Q1 2021 | $1,016,000 | +11.9% | 375,000 | 0.0% | 0.50% | -6.7% |
| Q4 2020 | $908,000 | – | 375,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,765,901 | $4,273,000 | 2.32% |
| NEA Management Company, LLC | 10,376,936 | $25,112,000 | 0.66% |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $478,000 | 0.62% |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $908,000 | 0.54% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $4,772,000 | 0.52% |
| BVF INC/IL | 4,012,404 | $9,710,000 | 0.38% |
| Avoro Capital Advisors LLC | 5,084,184 | $12,304,000 | 0.21% |
| FNY Investment Advisers, LLC | 200,000 | $484,000 | 0.13% |
| Boxer Capital, LLC | 1,134,453 | $2,745,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,745 | $316,000 | 0.05% |